Is there a place for F18-FDG PET/CT in the diagnosis o f primary breast cancer?

被引:1
|
作者
Morariu, Dragos Stefan [1 ,2 ]
Vlad, Catalin [1 ,2 ]
Puscas, Marius Emil [1 ,2 ]
Gata, Vlad [1 ,2 ]
Piciu, Doina [1 ,3 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Romania
[2] Oncol Inst Prof Dr Ion Chiricuta, Dept Surg Oncol, Cluj Napoca, Romania
[3] Oncol Inst Prof Dr Ion Chiricuta, Dept Nucl Med, Cluj Napoca, Romania
来源
JOURNAL OF BUON | 2020年 / 25卷 / 02期
关键词
breast cancer; F18; FDG; imaging technique; MRI; PET-CT; POSITRON-EMISSION-TOMOGRAPHY; HIGH FAMILIAL RISK; NEOADJUVANT CHEMOTHERAPY; FDG-PET/CT; MAMMOGRAPHY; MRI; WOMEN; ULTRASOUND; ACCURACY; US;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: With the improvement of techniques and the update of diagnostic protocols in breast cancer, modern imaging proves to be effective in the diagnosis of this pathology, as well as in its prognosis. This study aimed to evaluate the effectiveness of these modern imaging techniques through a systematic assessment of the most recent studies. Methods: A PUBMED search, using certain key combinations ("breast cancer", "F18 FDG PET-CT", "MRI", "staging", "diagnosis") and some inclusion and exclusion criteria, yielded 24 articles published during 2014-2018. Results: Using these 24 articles, the various statistical tests showed a significant difference between modern imaging techniques, with respect to prognosis (p<0.05), in close correlation with the immunohistochemical profile of the tumor. Conclusions: Modern imaging techniques (F18-FDG/PET-CT, F18-FDG/PET-MRI) were validated to formulate a better prognostic value than conventional imaging, presenting a sustainable higher sensitivity and specificity in evidencing the locoregional invasion and the recurrence of this pathology.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [1] Breast MRI and 18F FDG PET/CT in the management of breast cancer
    Iagaru, Andrei
    Masamed, Rinat
    Keesara, Sravanthi
    Conti, Peter S.
    ANNALS OF NUCLEAR MEDICINE, 2007, 21 (01) : 33 - 38
  • [2] Comparative studies PEM and PET-CT for breast cancer diagnostic with F18-FDG
    Sanchez Jurado, R.
    Ferrer Rebolleda, J.
    Cozar Santiago, M.
    Devis Saiz, M.
    Aguilar Barrios, J.
    Martinez Alonso, P.
    Vicedo Gonzalez, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S249 - S250
  • [3] 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
    Avril, Stefanie
    Muzic, Raymond F., Jr.
    Plecha, Donna
    Traughber, Bryan J.
    Vinayak, Shaveta
    Avril, Norbert
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 34S - 39S
  • [4] Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
    Sawicki, Lino M.
    Grueneisen, Johannes
    Schaarschmidt, Benedikt M.
    Buchbender, Christian
    Nagarajah, James
    Umutlu, Lale
    Antoch, Gerald
    Kinner, Sonja
    EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (02) : 459 - 465
  • [5] Breast MRI and18F FDG PET/CT in the management of breast cancer
    Andrei Iagaru
    Rinat Masamed
    Sravanthi Keesara
    Peter S. Conti
    Annals of Nuclear Medicine, 2007, 21 : 33 - 38
  • [6] Impact of Renal Failure on F18-FDG PET/CT Scans
    Kode, Vishwajit
    Karsch, Holly
    Osman, Medhat M.
    Muzaffar, Razi
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [7] 18F-FDG PET/CT for Staging and Restaging of Breast Cancer
    Groheux, David
    Cochet, Alexandre
    Humbert, Olivier
    Alberini, Jean-Louis
    Hindie, Elif
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 17S - 26S
  • [8] PET/CT with F18-FDG initial staging in patients with esophageal cancer
    Marti Samper, Alejandro
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2016, 20 (03): : 141 - 145
  • [9] Hibernoma: Intense Uptake on F18-FDG PET/CT
    Jong Deok Kim
    Hang Woo Lee
    Nuclear Medicine and Molecular Imaging, 2012, 46 (3) : 218 - 222
  • [10] F18-FDG PET/CT in a patient with Antisynthetase Syndrome
    Nazerani-Zemann, Tina
    Stanzel, Susanne
    Gstettner, Christian
    Aigner, Reingard Maria
    Pernthaler, Birgit
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2023, 62 (02): : 73 - 74